News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
782,517 Results
Type
Article (68883)
Company Profile (726)
Press Release (712908)
Section
Business (223443)
Career Advice (3225)
Deals (38108)
Drug Delivery (112)
Drug Development (88040)
Employer Resources (183)
FDA (17524)
Job Trends (16696)
News (379198)
Policy (37007)
Tag
Academia (2959)
Alliances (54185)
Alzheimer's disease (1322)
Approvals (17422)
Artificial intelligence (140)
Bankruptcy (381)
Best Places to Work (12478)
Biotechnology (499)
Breast cancer (124)
Cancer (1078)
Career advice (2717)
Cell therapy (243)
Clinical research (69398)
Collaboration (374)
Compensation (189)
COVID-19 (2781)
C-suite (96)
Data (1006)
Diabetes (158)
Diagnostics (6631)
Drug pricing (98)
Earnings (90208)
Employer resources (159)
Events (122400)
Executive appointments (282)
FDA (18018)
Funding (330)
Gene therapy (181)
GLP-1 (676)
Government (4902)
Healthcare (20622)
Infectious disease (2870)
Inflammatory bowel disease (118)
Interviews (616)
IPO (17209)
Job creations (4619)
Job search strategy (2263)
Layoffs (475)
Legal (9089)
Lung cancer (177)
Manufacturing (184)
Medical device (14316)
Medtech (14321)
Mergers & acquisitions (20925)
Metabolic disorders (440)
Neuroscience (1602)
NextGen Class of 2024 (7535)
Non-profit (5053)
Northern California (1373)
Obesity (256)
Opinion (238)
Patents (105)
People (62500)
Pharmaceutical (142)
Phase I (21448)
Phase II (30263)
Phase III (22793)
Pipeline (335)
Postmarket research (3181)
Preclinical (9453)
Radiopharmaceuticals (256)
Rare diseases (220)
Real estate (6994)
Regulatory (24379)
Research institute (2628)
Resumes & cover letters (502)
Southern California (1231)
Startups (4058)
United States (13567)
Vaccines (638)
Weight loss (210)
Date
Today (140)
Last 7 days (966)
Last 30 days (3553)
Last 365 days (37974)
2024 (33800)
2023 (42455)
2022 (53858)
2021 (58665)
2020 (57625)
2019 (51186)
2018 (38879)
2017 (35683)
2016 (36073)
2015 (42290)
2014 (37322)
2013 (34330)
2012 (34796)
2011 (35114)
2010 (34287)
Location
Africa (1041)
Arizona (215)
Asia (44904)
Australia (8127)
California (3210)
Canada (1236)
China (245)
Colorado (141)
Connecticut (156)
Europe (102964)
Florida (432)
Georgia (118)
Illinois (386)
Indiana (207)
Kansas (102)
Maryland (601)
Massachusetts (2656)
Michigan (167)
Minnesota (284)
New Jersey (935)
New York (932)
North Carolina (812)
Northern California (1374)
Ohio (139)
Pennsylvania (814)
South America (1427)
Southern California (1231)
Texas (458)
Washington State (379)
782,517 Results for "agenus formerly known as antigenics inc new york".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Assertio to Present at the Citizens JMP Life Sciences Conference in New York City
Assertio Holdings, Inc., a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief Financial Officer, will present at the Citizens JMP Life Sciences Conference to be held May 13, 2024 in New York City.
May 10, 2024
·
3 min read
BioMidwest
New Cohort Study Data Shows Baxter’s Expanded Hemodialysis – Known as HDx Therapy – Is Associated With Approximately 25% Lower Mortality Rate for up to Four Years
Baxter International Inc. announced new data showing expanded hemodialysis, known as HDx therapy, enabled by Theranova dialyzer, was associated with an approximately 25% lower all-cause mortality risk for up to four years when compared to high-flux hemodialysis.
May 29, 2024
·
5 min read
Pharm Country
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
Verrica Pharmaceuticals Inc. today announced that Ted White, President and Chief Executive Officer of Verrica Pharmaceuticals, will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City.
May 30, 2024
·
1 min read
Business
Assertio to Present at LD Micro Invitational Conference in New York City
Assertio Holdings, Inc. today announced that Ajay Patel, Chief Financial Officer, will present at the LD Micro Invitational XIV Conference to be held April 9, 2024 in New York City.
April 1, 2024
·
3 min read
Business
Lynx.MD Partners with New York Gastroenterology Associates to Enhance Gastrointestinal Research Efforts
Committed to advancing gastrointestinal research, Lynx.MD, the industry-leading medical data intelligence platform tailored specifically for the gastroenterology market, announces its collaboration with New York Gastroenterology Associates.
May 15, 2024
·
3 min read
Press Releases
Valneva Hosts Investor Day in New York City
October 10, 2024
·
5 min read
Press Releases
NeoGenomics Receives New York State Approval for Neo Comprehensive™ Solid Tumor Test
October 23, 2024
·
5 min read
BioMidwest
Anteris Provides Data Update on First in Human Study of DurAVR™ THV Presented at New York Valves 2024
Anteris Technologies Ltd announced a summation of the Company’s presentation at the New York Valves annual Conference held at the Jacob K. Javits Convention Center in New York City.
June 11, 2024
·
4 min read
Pharm Country
Newron Pharmaceuticals Reports on Its 2024 Investor Day in New York City
Newron Pharmaceuticals S.p.A., a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system, welcomed investors, analysts and media to its well-attended investor day in New York City.
June 25, 2024
·
10 min read
Spur Therapeutics (Formerly Freeline) Announces New Name and Brand
Spur Therapeutics, formerly Freeline Therapeutics, today announced a new name and brand to reflect its focus on developing a new generation of gene therapies and advancing the practice of genetic medicine.
June 17, 2024
·
5 min read
1 of 78,252
Next
